We work with biopharma organizations at commercial inflection points.
The trigger is often a launch.
The need is almost always broader.

FDA clearance is closer than expected.
The organization has never commercialized in-house.
Not as a rhetorical question. As the kind that keeps her up at night.
Where Alexander Jamison comes in:
Builds the governance infrastructure before launch exposes what the organization does not yet have.
The first launch worked well enough.
But leadership knows where the organization struggled.
Now there are two assets, one commercial organization, and a timeline that will not allow the same improvisation.
Where Alexander Jamison comes in:
Identifies what broke in the first launch — and designs the architecture that holds under the demands of the second


The board is asking harder questions.
Portfolio prioritization.
Resource allocation.
Commercial readiness.
The CEO needs to answer with clarity — not just confidence.
Where Alexander Jamison comes in:
Designs governance and enterprise visibility architecture that makes board conversations structured, defensible, and proactive.
Decision cycles elongated.
Cross-functional alignment broke down at critical moments.
The right people were not always in the right rooms.
Leadership knows what went wrong.
But the architecture to prevent it from happening again does not yet exist.
Where Alexander Jamison comes in:
Identifies the structural causes of the friction — and designs the system that fixes the root, not the symptom.


A second geography exposes governance gaps that proximity and informal coordination once hid.
What worked in one market will not work in two.
Where Alexander Jamison comes in:
Designs governance architecture that scales across markets without losing accountability or decision velocity.
Accountable for commercial readiness, board confidence, and whether the organization is structured for what comes next.
Owns execution. Needs governance infrastructure that works — not another strategy deck.
Accountable for capital allocation, partner spend, and ROI. Requires a portfolio governance model that is defensible.
We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.